Prediction: Lipitor to Cede the ‘Best-Selling’ Crown to Humira


Published On: May 3rd, 2010

By 2016, the drug’s annual sales will haveclimbed to $10.1 billion, putting it ahead of Roche’s cancer drug Avastin (with $8.9 billion in sales), predicts EvaluatePharma, a London-based research firm.

View original here: 
Prediction: Lipitor to Cede the ‘Best-Selling’ Crown to Humira



Loading...


Comments are closed.